Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

Objective: Tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis decreases sexual acquisition of HIV infection. We sought to evaluate the renal safety of TDF in HIV-uninfected persons. Design and methods: The Iniciativa Profilaxis Pre-Exposición (iPrEx) study randomly assigned 2499 HIV-serone...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marc M. Solomon, Javier R. Lama, David V. Glidden, Kathleen Mulligan, Vanessa McMahan, Albert Y. Liu, Juan Vicente Guanira, Valdilea G. Veloso, Kenneth H. Mayer, Suwat Chariyalertsak, Mauro Schechter, Linda Gail Bekker, Esper Georges Kallás, David N. Burns, Robert M. Grant
Format:	Journal
Published:	2018
Subjects:	Immunology and Microbiology Medicine
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84898016347&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/53611
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
by: Marc M. Solomon, et al.
Published: (2018)

Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
by: David V. Glidden, et al.
Published: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
by: Solomon M.M., et al.
Published: (2014)

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Peter L. Anderson, et al.
Published: (2018)

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Anderson P., et al.
Published: (2017)

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
by: Marc M. Solomon, et al.
Published: (2018)

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
by: Solomon M., et al.
Published: (2017)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
by: Alex Carballo-Diéguez, et al.
Published: (2018)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
by: Alex Carballo-Diéguez, et al.
Published: (2018)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
by: Avihingsanon A.
Published: (2023)

Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review
by: Marieke Bierhoff, et al.
Published: (2020)

Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial
by: Patawee Boontanondha, et al.
Published: (2020)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
by: Vera E. Bukkems, et al.
Published: (2020)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
by: Torsak Bunupuradah, et al.
Published: (2018)

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
by: Phuphuakrat A.
Published: (2023)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
by: Tim R. Cressey, et al.
Published: (2018)

Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
by: Paul K. Drain, et al.
Published: (2020)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
by: Tavitiya Sudjaritruk, et al.
Published: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
by: Tavitiya Sudjaritruk, et al.
Published: (2018)

Tenofovir Disoproxil Fumarate (TDF) Prenatal Sebagai Pelengkap Tatalaksana Pencegahan Transmisi Vertikal Virus Hepatitis B
by: Avianita Dewi Kusumawardhani
Published: (2020)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
by: Linda Aurpibul, et al.
Published: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
by: Linda Aurpibul, et al.
Published: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
by: Linda Aurpibul, et al.
Published: (2018)

Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors
by: Geoffroy Liegeon, et al.
Published: (2019)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
by: Supawadee Suppadungsuk, et al.
Published: (2022)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
by: Suppadungsuk S.
Published: (2023)

Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review
by: Bagus Setyoboedi, Bagus, et al.

Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis
by: David V. Glidden, et al.
Published: (2018)

Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis
by: David V. Glidden, et al.
Published: (2018)

Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, noninferiority trial
by: Pedro Cahn, et al.
Published: (2019)

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
by: Pedro Cahn, et al.
Published: (2018)

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial
by: Kathleen Mulligan, et al.
Published: (2018)

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial
by: Kathleen Mulligan, et al.
Published: (2018)

Incidence rate and time to occurrence of renal impairment and chronic kidney disease among thai hiv-infected adults with tenofovir disoproxil fumarate use
by: Jirayu Visuthranukul, et al.
Published: (2022)

Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
by: Marieke Bierhoff, et al.
Published: (2022)

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
by: Marc M. Solomon, et al.
Published: (2018)

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
by: Marc M. Solomon, et al.
Published: (2018)

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014
by: Melvin A.J.
Published: (2023)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
by: Tim R. Cressey, et al.
Published: (2018)